Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-10-31

AUTHORS

Mathieu Gauthé, Cyrielle Aveline, Frédéric Lecouvet, Laure Michaud, Caroline Rousseau, Marc Tassart, Olivier Cussenot, Jean-Noël Talbot, Isabelle Durand-Zaleski

ABSTRACT

PurposeTo compare the impact of 18F-sodium-fluoride (NaF) PET/CT, 18F-fluorocholine (FCH) PET/CT and diffusion-weighted whole-body MRI (DW-MRI) on the management of patients with prostate cancer (PCa) suspicious for distant metastasis.MethodsProstate cancer patients were prospectively included between December 2011 and August 2014 and benefited from these three whole-body imaging (WBI) modalities within 1 month in addition to the standard PCa workup. Management was prospectively decided by clinicians during two multidisciplinary meetings, before and after the whole-body imaging workup. Rates of induced changes of whole-body imaging modalities were compared by Cochran’s Q test.ResultsOne-hundred-one patients (27 at staging, 59 at first biochemical recurrence (BCR) and 15 at first episode of rising serum level of prostate-specific antigen during androgen-deprivation therapy) were included. The overall rate of management changes was 52%: 29% as a consequence of WBI, higher for FCH-PET/CT than for NaF-PET/CT or DW-MRI (p < 0.0001) and highest (41%) for FCH-PET/CT at BCR. Actual management was adequate in all patients but two.ConclusionsWhole-body imaging induced a change in management in approximately a third of PCa patients suspicious for metastasis. The impact rate was determined to be greatest at first BCR using FCH-PET/CT. NaF-PET/CT and DW-MRI seemed less useful in this context. More... »

PAGES

1587-1595

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00345-018-2547-5

DOI

http://dx.doi.org/10.1007/s00345-018-2547-5

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107950852

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30382380


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Choline", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diffusion Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorine Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neoplasm Metastasis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron Emission Tomography Computed Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prostatic Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sodium Fluoride", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.50550.35", 
          "name": [
            "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France", 
            "AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gauth\u00e9", 
        "givenName": "Mathieu", 
        "id": "sg:person.01121730347.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121730347.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aveline", 
        "givenName": "Cyrielle", 
        "id": "sg:person.07401136226.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07401136226.60"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, Centre du Cancer, Institut de Recherche Exp\u00e9rimentale Et Clinique, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.48769.34", 
          "name": [
            "Department of Radiology, Centre du Cancer, Institut de Recherche Exp\u00e9rimentale Et Clinique, Cliniques Universitaires Saint-Luc, Universit\u00e9 Catholique de Louvain, Brussels, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lecouvet", 
        "givenName": "Fr\u00e9d\u00e9ric", 
        "id": "sg:person.01204666563.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204666563.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michaud", 
        "givenName": "Laure", 
        "id": "sg:person.01313114637.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313114637.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nantes-Angers Cancer Research Centre, INSERM U892, CNRS UMR 6299, Universit\u00e9 de Nantes, Nantes, France", 
          "id": "http://www.grid.ac/institutes/grid.4817.a", 
          "name": [
            "Nuclear Medicine Unit, ICO Gauducheau Cancer Centre, Saint-Herblain, France", 
            "Nantes-Angers Cancer Research Centre, INSERM U892, CNRS UMR 6299, Universit\u00e9 de Nantes, Nantes, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rousseau", 
        "givenName": "Caroline", 
        "id": "sg:person.01240530667.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, H\u00f4pital Tenon, AP-HP, Sorbonne Universit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Radiology, H\u00f4pital Tenon, AP-HP, Sorbonne Universit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tassart", 
        "givenName": "Marc", 
        "id": "sg:person.0715455156.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715455156.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "GRC No 5, ONCOTYPE-URO, Institut Universitaire de Canc\u00e9rologie, Sorbonne Universit\u00e9, Paris, France", 
          "id": "http://www.grid.ac/institutes/grid.462844.8", 
          "name": [
            "Department of Urology, H\u00f4pital Tenon, AP-HP, Sorbonne Universit\u00e9, Paris, France", 
            "GRC No 5, ONCOTYPE-URO, Institut Universitaire de Canc\u00e9rologie, Sorbonne Universit\u00e9, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cussenot", 
        "givenName": "Olivier", 
        "id": "sg:person.013241233644.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241233644.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Nuclear Medicine, H\u00f4pital Tenon, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Sorbonne Universit\u00e9, 4 rue de la Chine, 75020, Paris, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Talbot", 
        "givenName": "Jean-No\u00ebl", 
        "id": "sg:person.07715603712.83", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07715603712.83"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Service de Sant\u00e9 Publique, H\u00f4pital Henri Mondor, AP-HP, Universit\u00e9 Paris 12, Cr\u00e9teil, France", 
          "id": "http://www.grid.ac/institutes/grid.412116.1", 
          "name": [
            "AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France", 
            "Service de Sant\u00e9 Publique, H\u00f4pital Henri Mondor, AP-HP, Universit\u00e9 Paris 12, Cr\u00e9teil, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Durand-Zaleski", 
        "givenName": "Isabelle", 
        "id": "sg:person.01327533357.46", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s00330-010-1879-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015311128", 
          "https://doi.org/10.1007/s00330-010-1879-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-014-2872-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016743164", 
          "https://doi.org/10.1007/s00259-014-2872-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-016-1078-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007912311", 
          "https://doi.org/10.1007/s12149-016-1078-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-013-2525-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010481232", 
          "https://doi.org/10.1007/s00259-013-2525-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12149-010-0393-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002122144", 
          "https://doi.org/10.1007/s12149-010-0393-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-008-0788-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006843363", 
          "https://doi.org/10.1007/s00259-008-0788-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00259-012-2083-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005749714", 
          "https://doi.org/10.1007/s00259-012-2083-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00256-014-1903-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045392685", 
          "https://doi.org/10.1007/s00256-014-1903-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-10-31", 
    "datePublishedReg": "2018-10-31", 
    "description": "PurposeTo compare the impact of 18F-sodium-fluoride (NaF) PET/CT, 18F-fluorocholine (FCH) PET/CT and diffusion-weighted whole-body MRI (DW-MRI) on the management of patients with prostate cancer (PCa) suspicious for distant metastasis.MethodsProstate cancer patients were prospectively included between December 2011 and August 2014 and benefited from these three whole-body imaging (WBI) modalities within 1\u00a0month in addition to the standard PCa workup. Management was prospectively decided by clinicians during two multidisciplinary meetings, before and after the whole-body imaging workup. Rates of induced changes of whole-body imaging modalities were compared by Cochran\u2019s Q test.ResultsOne-hundred-one patients (27 at staging, 59 at first biochemical recurrence (BCR) and 15 at first episode of rising serum level of prostate-specific antigen during androgen-deprivation therapy) were included. The overall rate of management changes was 52%: 29% as a consequence of WBI, higher for FCH-PET/CT than for NaF-PET/CT or DW-MRI (p\u2009<\u20090.0001) and highest (41%) for FCH-PET/CT at BCR. Actual management was adequate in all patients but two.ConclusionsWhole-body imaging induced a change in management in approximately a third of PCa patients suspicious for metastasis. The impact rate was determined to be greatest at first BCR using FCH-PET/CT. NaF-PET/CT and DW-MRI seemed less useful in this context.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00345-018-2547-5", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094127", 
        "issn": [
          "0724-4983", 
          "1433-8726"
        ], 
        "name": "World Journal of Urology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "8", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "37"
      }
    ], 
    "keywords": [
      "FCH PET/CT", 
      "PET/CT", 
      "diffusion-weighted whole-body MRI", 
      "NaF PET/CT", 
      "management of patients", 
      "prostate cancer", 
      "Q test", 
      "whole-body diffusion-weighted MRI", 
      "MethodsProstate cancer patients", 
      "prospective multicentre study", 
      "imaging modalities", 
      "whole-body MRI", 
      "Cochran's Q test", 
      "diffusion-weighted MRI", 
      "distant metastasis", 
      "ResultsOne hundred", 
      "PCa patients", 
      "multicentre study", 
      "cancer patients", 
      "multidisciplinary meeting", 
      "patients", 
      "metastasis", 
      "CT", 
      "overall rate", 
      "workup", 
      "cancer", 
      "impact of sodium", 
      "MRI", 
      "actual management", 
      "modalities", 
      "BCR", 
      "management", 
      "PurposeTo", 
      "clinicians", 
      "months", 
      "induced changes", 
      "rate", 
      "changes", 
      "management changes", 
      "WBI", 
      "imaging", 
      "third", 
      "sodium", 
      "study", 
      "impact", 
      "test", 
      "meeting", 
      "addition", 
      "consequences", 
      "context", 
      "impact rate"
    ], 
    "name": "Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study", 
    "pagination": "1587-1595", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107950852"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00345-018-2547-5"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30382380"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00345-018-2547-5", 
      "https://app.dimensions.ai/details/publication/pub.1107950852"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-09-02T16:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220902/entities/gbq_results/article/article_766.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00345-018-2547-5"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2547-5'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2547-5'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2547-5'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00345-018-2547-5'


 

This table displays all metadata directly associated to this object as RDF triples.

281 TRIPLES      21 PREDICATES      99 URIs      82 LITERALS      21 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00345-018-2547-5 schema:about N2e9936761a7044719cf799abf82c7591
2 N393e991351374c49b84531a03e32e1df
3 N39cc46e75c5549fb82c5030df6f55c2f
4 N71c00d38e78e4bafa682e91799e56c94
5 N8de6348fdd4f429f83a21f4405d04a17
6 Naa7594a1a90745ada5820411b7bf019b
7 Nbe849536da3d460dadec4eaae9822ae3
8 Nd66c5a7f471748ed9924ce3c320bf86e
9 Nd68618c2451b4945ab18cc73c63c39e3
10 Ne59c25ab2da7470995e902a0da0510a0
11 Nf046105efe01455abd20ee870065e737
12 Nf1b21e7d0f4a4aa98d6393a3c1e06901
13 Nf949bef4a8be4c4786d3ce93e6c07772
14 Nffb5f138da3547bc84b35d2d76fefba1
15 anzsrc-for:11
16 anzsrc-for:1103
17 anzsrc-for:1112
18 schema:author N8b3a1905b0054d9d9531440e2ba45c95
19 schema:citation sg:pub.10.1007/s00256-014-1903-9
20 sg:pub.10.1007/s00259-008-0788-z
21 sg:pub.10.1007/s00259-012-2083-2
22 sg:pub.10.1007/s00259-013-2525-5
23 sg:pub.10.1007/s00259-014-2872-x
24 sg:pub.10.1007/s00330-010-1879-3
25 sg:pub.10.1007/s12149-010-0393-7
26 sg:pub.10.1007/s12149-016-1078-7
27 schema:datePublished 2018-10-31
28 schema:datePublishedReg 2018-10-31
29 schema:description PurposeTo compare the impact of 18F-sodium-fluoride (NaF) PET/CT, 18F-fluorocholine (FCH) PET/CT and diffusion-weighted whole-body MRI (DW-MRI) on the management of patients with prostate cancer (PCa) suspicious for distant metastasis.MethodsProstate cancer patients were prospectively included between December 2011 and August 2014 and benefited from these three whole-body imaging (WBI) modalities within 1 month in addition to the standard PCa workup. Management was prospectively decided by clinicians during two multidisciplinary meetings, before and after the whole-body imaging workup. Rates of induced changes of whole-body imaging modalities were compared by Cochran’s Q test.ResultsOne-hundred-one patients (27 at staging, 59 at first biochemical recurrence (BCR) and 15 at first episode of rising serum level of prostate-specific antigen during androgen-deprivation therapy) were included. The overall rate of management changes was 52%: 29% as a consequence of WBI, higher for FCH-PET/CT than for NaF-PET/CT or DW-MRI (p < 0.0001) and highest (41%) for FCH-PET/CT at BCR. Actual management was adequate in all patients but two.ConclusionsWhole-body imaging induced a change in management in approximately a third of PCa patients suspicious for metastasis. The impact rate was determined to be greatest at first BCR using FCH-PET/CT. NaF-PET/CT and DW-MRI seemed less useful in this context.
30 schema:genre article
31 schema:isAccessibleForFree false
32 schema:isPartOf Na9f29b5083634a2d839a3edb858ad60c
33 Nb6a23901c75d417cb4b091f3db6cf18a
34 sg:journal.1094127
35 schema:keywords BCR
36 CT
37 Cochran's Q test
38 FCH PET/CT
39 MRI
40 MethodsProstate cancer patients
41 NaF PET/CT
42 PCa patients
43 PET/CT
44 PurposeTo
45 Q test
46 ResultsOne hundred
47 WBI
48 actual management
49 addition
50 cancer
51 cancer patients
52 changes
53 clinicians
54 consequences
55 context
56 diffusion-weighted MRI
57 diffusion-weighted whole-body MRI
58 distant metastasis
59 imaging
60 imaging modalities
61 impact
62 impact of sodium
63 impact rate
64 induced changes
65 management
66 management changes
67 management of patients
68 meeting
69 metastasis
70 modalities
71 months
72 multicentre study
73 multidisciplinary meeting
74 overall rate
75 patients
76 prospective multicentre study
77 prostate cancer
78 rate
79 sodium
80 study
81 test
82 third
83 whole-body MRI
84 whole-body diffusion-weighted MRI
85 workup
86 schema:name Impact of sodium 18F-fluoride PET/CT, 18F-fluorocholine PET/CT and whole-body diffusion-weighted MRI on the management of patients with prostate cancer suspicious for metastasis: a prospective multicentre study
87 schema:pagination 1587-1595
88 schema:productId N377694ab747248cab60fafc79259f012
89 N51f6d9c68ff24a7e9c7aed69b92c97f9
90 N7a8d939c32034e75b6cab7540cc364dd
91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107950852
92 https://doi.org/10.1007/s00345-018-2547-5
93 schema:sdDatePublished 2022-09-02T16:01
94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
95 schema:sdPublisher N1b8332914515475f8529dc54bd177275
96 schema:url https://doi.org/10.1007/s00345-018-2547-5
97 sgo:license sg:explorer/license/
98 sgo:sdDataset articles
99 rdf:type schema:ScholarlyArticle
100 N01277591f4554cae874e51c967e03302 rdf:first sg:person.0715455156.36
101 rdf:rest Nfa0864c209f3460d94c485f0292d9b46
102 N1b8332914515475f8529dc54bd177275 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 N2e9936761a7044719cf799abf82c7591 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Radiopharmaceuticals
106 rdf:type schema:DefinedTerm
107 N377694ab747248cab60fafc79259f012 schema:name doi
108 schema:value 10.1007/s00345-018-2547-5
109 rdf:type schema:PropertyValue
110 N390ee9012c524ff1ba680dee9eb85670 rdf:first sg:person.01240530667.47
111 rdf:rest N01277591f4554cae874e51c967e03302
112 N393e991351374c49b84531a03e32e1df schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Neoplasm Metastasis
114 rdf:type schema:DefinedTerm
115 N39cc46e75c5549fb82c5030df6f55c2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Diffusion Magnetic Resonance Imaging
117 rdf:type schema:DefinedTerm
118 N51f6d9c68ff24a7e9c7aed69b92c97f9 schema:name dimensions_id
119 schema:value pub.1107950852
120 rdf:type schema:PropertyValue
121 N5a2642681f7c4cd0b74c21efad5309cb rdf:first sg:person.01313114637.12
122 rdf:rest N390ee9012c524ff1ba680dee9eb85670
123 N61b339cfc6ed4b56a2497e66d39a6f9d rdf:first sg:person.07401136226.60
124 rdf:rest Nd9bfca6f5ece4169ad00055a040f764f
125 N6ccc4be9b36d42e69f07a73bf0c9b815 rdf:first sg:person.07715603712.83
126 rdf:rest Nf0fc9fc806954a5db1e52af6f1f428d2
127 N71c00d38e78e4bafa682e91799e56c94 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Prostatic Neoplasms
129 rdf:type schema:DefinedTerm
130 N7a8d939c32034e75b6cab7540cc364dd schema:name pubmed_id
131 schema:value 30382380
132 rdf:type schema:PropertyValue
133 N8b3a1905b0054d9d9531440e2ba45c95 rdf:first sg:person.01121730347.36
134 rdf:rest N61b339cfc6ed4b56a2497e66d39a6f9d
135 N8de6348fdd4f429f83a21f4405d04a17 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Sodium Fluoride
137 rdf:type schema:DefinedTerm
138 Na9f29b5083634a2d839a3edb858ad60c schema:volumeNumber 37
139 rdf:type schema:PublicationVolume
140 Naa7594a1a90745ada5820411b7bf019b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Aged
142 rdf:type schema:DefinedTerm
143 Nb6a23901c75d417cb4b091f3db6cf18a schema:issueNumber 8
144 rdf:type schema:PublicationIssue
145 Nbe849536da3d460dadec4eaae9822ae3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Male
147 rdf:type schema:DefinedTerm
148 Nd66c5a7f471748ed9924ce3c320bf86e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged, 80 and over
150 rdf:type schema:DefinedTerm
151 Nd68618c2451b4945ab18cc73c63c39e3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Choline
153 rdf:type schema:DefinedTerm
154 Nd9bfca6f5ece4169ad00055a040f764f rdf:first sg:person.01204666563.57
155 rdf:rest N5a2642681f7c4cd0b74c21efad5309cb
156 Ne59c25ab2da7470995e902a0da0510a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Humans
158 rdf:type schema:DefinedTerm
159 Nf046105efe01455abd20ee870065e737 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Prospective Studies
161 rdf:type schema:DefinedTerm
162 Nf0fc9fc806954a5db1e52af6f1f428d2 rdf:first sg:person.01327533357.46
163 rdf:rest rdf:nil
164 Nf1b21e7d0f4a4aa98d6393a3c1e06901 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Middle Aged
166 rdf:type schema:DefinedTerm
167 Nf949bef4a8be4c4786d3ce93e6c07772 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Fluorine Radioisotopes
169 rdf:type schema:DefinedTerm
170 Nfa0864c209f3460d94c485f0292d9b46 rdf:first sg:person.013241233644.08
171 rdf:rest N6ccc4be9b36d42e69f07a73bf0c9b815
172 Nffb5f138da3547bc84b35d2d76fefba1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Positron Emission Tomography Computed Tomography
174 rdf:type schema:DefinedTerm
175 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
176 schema:name Medical and Health Sciences
177 rdf:type schema:DefinedTerm
178 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
179 schema:name Clinical Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
182 schema:name Oncology and Carcinogenesis
183 rdf:type schema:DefinedTerm
184 sg:journal.1094127 schema:issn 0724-4983
185 1433-8726
186 schema:name World Journal of Urology
187 schema:publisher Springer Nature
188 rdf:type schema:Periodical
189 sg:person.01121730347.36 schema:affiliation grid-institutes:grid.50550.35
190 schema:familyName Gauthé
191 schema:givenName Mathieu
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01121730347.36
193 rdf:type schema:Person
194 sg:person.01204666563.57 schema:affiliation grid-institutes:grid.48769.34
195 schema:familyName Lecouvet
196 schema:givenName Frédéric
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01204666563.57
198 rdf:type schema:Person
199 sg:person.01240530667.47 schema:affiliation grid-institutes:grid.4817.a
200 schema:familyName Rousseau
201 schema:givenName Caroline
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47
203 rdf:type schema:Person
204 sg:person.01313114637.12 schema:affiliation grid-institutes:None
205 schema:familyName Michaud
206 schema:givenName Laure
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313114637.12
208 rdf:type schema:Person
209 sg:person.013241233644.08 schema:affiliation grid-institutes:grid.462844.8
210 schema:familyName Cussenot
211 schema:givenName Olivier
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013241233644.08
213 rdf:type schema:Person
214 sg:person.01327533357.46 schema:affiliation grid-institutes:grid.412116.1
215 schema:familyName Durand-Zaleski
216 schema:givenName Isabelle
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01327533357.46
218 rdf:type schema:Person
219 sg:person.0715455156.36 schema:affiliation grid-institutes:None
220 schema:familyName Tassart
221 schema:givenName Marc
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0715455156.36
223 rdf:type schema:Person
224 sg:person.07401136226.60 schema:affiliation grid-institutes:None
225 schema:familyName Aveline
226 schema:givenName Cyrielle
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07401136226.60
228 rdf:type schema:Person
229 sg:person.07715603712.83 schema:affiliation grid-institutes:None
230 schema:familyName Talbot
231 schema:givenName Jean-Noël
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07715603712.83
233 rdf:type schema:Person
234 sg:pub.10.1007/s00256-014-1903-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045392685
235 https://doi.org/10.1007/s00256-014-1903-9
236 rdf:type schema:CreativeWork
237 sg:pub.10.1007/s00259-008-0788-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1006843363
238 https://doi.org/10.1007/s00259-008-0788-z
239 rdf:type schema:CreativeWork
240 sg:pub.10.1007/s00259-012-2083-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005749714
241 https://doi.org/10.1007/s00259-012-2083-2
242 rdf:type schema:CreativeWork
243 sg:pub.10.1007/s00259-013-2525-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010481232
244 https://doi.org/10.1007/s00259-013-2525-5
245 rdf:type schema:CreativeWork
246 sg:pub.10.1007/s00259-014-2872-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1016743164
247 https://doi.org/10.1007/s00259-014-2872-x
248 rdf:type schema:CreativeWork
249 sg:pub.10.1007/s00330-010-1879-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015311128
250 https://doi.org/10.1007/s00330-010-1879-3
251 rdf:type schema:CreativeWork
252 sg:pub.10.1007/s12149-010-0393-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002122144
253 https://doi.org/10.1007/s12149-010-0393-7
254 rdf:type schema:CreativeWork
255 sg:pub.10.1007/s12149-016-1078-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007912311
256 https://doi.org/10.1007/s12149-016-1078-7
257 rdf:type schema:CreativeWork
258 grid-institutes:None schema:alternateName Department of Nuclear Medicine, Hôpital Tenon, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne Université, 4 rue de la Chine, 75020, Paris, France
259 Department of Radiology, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
260 schema:name Department of Nuclear Medicine, Hôpital Tenon, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne Université, 4 rue de la Chine, 75020, Paris, France
261 Department of Radiology, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
262 rdf:type schema:Organization
263 grid-institutes:grid.412116.1 schema:alternateName Service de Santé Publique, Hôpital Henri Mondor, AP-HP, Université Paris 12, Créteil, France
264 schema:name AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France
265 Service de Santé Publique, Hôpital Henri Mondor, AP-HP, Université Paris 12, Créteil, France
266 rdf:type schema:Organization
267 grid-institutes:grid.462844.8 schema:alternateName GRC No 5, ONCOTYPE-URO, Institut Universitaire de Cancérologie, Sorbonne Université, Paris, France
268 schema:name Department of Urology, Hôpital Tenon, AP-HP, Sorbonne Université, Paris, France
269 GRC No 5, ONCOTYPE-URO, Institut Universitaire de Cancérologie, Sorbonne Université, Paris, France
270 rdf:type schema:Organization
271 grid-institutes:grid.4817.a schema:alternateName Nantes-Angers Cancer Research Centre, INSERM U892, CNRS UMR 6299, Université de Nantes, Nantes, France
272 schema:name Nantes-Angers Cancer Research Centre, INSERM U892, CNRS UMR 6299, Université de Nantes, Nantes, France
273 Nuclear Medicine Unit, ICO Gauducheau Cancer Centre, Saint-Herblain, France
274 rdf:type schema:Organization
275 grid-institutes:grid.48769.34 schema:alternateName Department of Radiology, Centre du Cancer, Institut de Recherche Expérimentale Et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
276 schema:name Department of Radiology, Centre du Cancer, Institut de Recherche Expérimentale Et Clinique, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
277 rdf:type schema:Organization
278 grid-institutes:grid.50550.35 schema:alternateName AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France
279 schema:name AP-HP Health Economics Research Unit, INSERM UMR 1123, Paris, France
280 Department of Nuclear Medicine, Hôpital Tenon, Assistance Publique Hôpitaux de Paris (AP-HP), Sorbonne Université, 4 rue de la Chine, 75020, Paris, France
281 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...